Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

UNITED THERAPEUTICS (UTHR) Shares Issued: 2009-2025

Historic Shares Issued for UNITED THERAPEUTICS (UTHR) over the last 15 years, with Sep 2025 value amounting to $40.2 million.

  • UNITED THERAPEUTICS's Shares Issued rose 23.69% to $40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.6 million, marking a year-over-year decrease of 24.98%. This contributed to the annual value of $152.5 million for FY2024, which is 55.61% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Shares Issued of $40.2 million as of Q3 2025, which was up 122.10% from $18.1 million recorded in Q2 2025.
  • UNITED THERAPEUTICS's Shares Issued's 5-year high stood at $61.4 million during Q1 2023, with a 5-year trough of $4.3 million in Q1 2022.
  • For the 3-year period, UNITED THERAPEUTICS's Shares Issued averaged around $29.6 million, with its median value being $25.7 million (2024).
  • The largest annual percentage gain for UNITED THERAPEUTICS's Shares Issued in the last 5 years was 1,327.91% (2023), contrasted with its biggest fall of 86.85% (2023).
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Shares Issued stood at $7.7 million in 2021, then soared by 620.78% to $55.5 million in 2022, then plummeted by 86.85% to $7.3 million in 2023, then soared by 252.05% to $25.7 million in 2024, then rose by 23.69% to $40.2 million in 2025.
  • Its last three reported values are $40.2 million in Q3 2025, $18.1 million for Q2 2025, and $16.6 million during Q1 2025.